SLC39A10通过MAPK14 (p38α) 途径驱动M2巨细胞极化和胃癌的进展

Yinhua Liang1, Mengting Li1, Chihao Zhang1

  • 1Department of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

iScience
|January 15, 2026
PubMed
概括

载体SLC39A10通过激活瘤细胞中的MAPK14并促进M2巨细胞的两极分化,驱动胃癌 (GC) 的进展. 这个轴为免疫抑制瘤微环境 (TME) 提供燃料,提供治疗点.